P3 Health Partners (NASDAQ:PIII – Get Free Report) and Acadia Healthcare (NASDAQ:ACHC – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.
Volatility and Risk
P3 Health Partners has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500.
Earnings & Valuation
This table compares P3 Health Partners and Acadia Healthcare”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| P3 Health Partners | $1.46 billion | 0.04 | -$147.95 million | ($33.00) | -0.27 |
| Acadia Healthcare | $3.31 billion | 0.77 | -$1.10 billion | ($12.45) | -2.21 |
P3 Health Partners has higher earnings, but lower revenue than Acadia Healthcare. Acadia Healthcare is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and target prices for P3 Health Partners and Acadia Healthcare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| P3 Health Partners | 1 | 2 | 1 | 0 | 2.00 |
| Acadia Healthcare | 2 | 5 | 7 | 1 | 2.47 |
P3 Health Partners currently has a consensus price target of $17.00, indicating a potential upside of 89.31%. Acadia Healthcare has a consensus price target of $29.85, indicating a potential upside of 8.53%. Given P3 Health Partners’ higher probable upside, equities research analysts clearly believe P3 Health Partners is more favorable than Acadia Healthcare.
Profitability
This table compares P3 Health Partners and Acadia Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| P3 Health Partners | -6.55% | N/A | -16.40% |
| Acadia Healthcare | -33.44% | 6.19% | 2.42% |
Insider & Institutional Ownership
7.7% of P3 Health Partners shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by company insiders. Comparatively, 1.2% of Acadia Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Acadia Healthcare beats P3 Health Partners on 8 of the 15 factors compared between the two stocks.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
About Acadia Healthcare
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
